|
TIGD7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.185600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.632600E-01 |
| Normal-vs-Stage2 |
9.719000E-01 |
| Normal-vs-Stage3 |
6.587600E-01 |
| Normal-vs-Stage4 |
5.044400E-01 |
| Stage1-vs-Stage2 |
8.381400E-01 |
| Stage1-vs-Stage3 |
5.055400E-01 |
| Stage1-vs-Stage4 |
4.644000E-01 |
| Stage2-vs-Stage3 |
7.901400E-01 |
| Stage2-vs-Stage4 |
4.822200E-01 |
| Stage3-vs-Stage4 |
6.211400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.619400E-01 |
| Normal-vs-AfricanAmerican |
9.660200E-01 |
| Normal-vs-Asian |
5.616800E-01 |
| Caucasian-vs-AfricanAmerican |
3.731000E-01 |
| Caucasian-vs-Asian |
9.760000E-01 |
| AfricanAmerican-vs-Asian |
7.029800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.396200E-01 |
| Normal-vs-Female |
6.566000E-02 |
| Male-vs-Female |
5.478100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.480400E-01 |
| Normal-vs-Extreme_Weight |
6.378400E-01 |
| Normal-vs-Obese |
1.386830E-01 |
| Normal-vs-Extreme_Obese |
7.932400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.909000E-01 |
| Normal_Weight-vs-Obese |
1.294360E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.645400E-01 |
| Extreme_Weight-vs-Obese |
7.351700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.762000E-01 |
| Obese-vs-Extreme_Obese |
3.819000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.630300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.778300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.464600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.250200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.395000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.692300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.512200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.830180E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.239800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.011000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.381600E-01 |
| Normal-VS-Type2 PRCC |
1.388040E-02 |
| Normal-VS-KIRP CIMP |
1.154230E-02 |
| Normal-VS-Unclassified PRCC |
4.942500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.378540E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.844250E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.401190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.75560000004182E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.321150E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.330200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.875790E-01 |
| Normal-vs-N1 |
5.466400E-02 |
| Normal-vs-N2 |
9.556400E-01 |
| N0-vs-N1 |
1.774110E-02 |
| N0-vs-N2 |
5.825400E-01 |
| N1-vs-N2 |
4.432200E-01 |
|
|
